TrademarkDir
ELIXIR BEAUTY BY ASHLEY MANDELL
LIVE

Serial Number

90236822

Owner

Bravado Pharmaceuticals, LLC

First Use Date

May 1, 2012

Filing Date

Oct 6, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ELIXIR BEAUTY BY ASHLEY MANDELL Trademark

Serial Number: 90236822 • Registration: 6556759

ELIXIR BEAUTY BY ASHLEY MANDELL is a trademark filed by Bravado Pharmaceuticals, LLC on October 6, 2020. The trademark is classified under Class 3 (Cosmetics & Cleaning). The application is currently registered and active.

Owner Contact Info

Bravado Pharmaceuticals, LLC (2 trademarks)

27105 Brush Creek Way
Wesley Chapel, FL 33544

Entity Type: 16

Trademark Details

Filing Date

October 6, 2020

Registration Date

November 9, 2021

First Use Anywhere

May 1, 2012

First Use in Commerce

May 1, 2012

Published for Opposition

April 13, 2021

Filing History

REGISTERED-PRINCIPAL REGISTER
Nov 9, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 2, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 1, 2021 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Sep 30, 2021 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 30, 2021 AITU
USE AMENDMENT FILED
Sep 16, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 16, 2021 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 8, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 13, 2021 NPUB
PUBLISHED FOR OPPOSITION
Apr 13, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 24, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 8, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 8, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 8, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 8, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 8, 2021 CNEA
ASSIGNED TO EXAMINER
Mar 5, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 19, 2020 NWOS

Related Trademarks

More from this Owner

MERGING CLASSICAL PHARMACEUTICS WITH CUTTING EDGE INNOVATION AND TECHNOLOGY

MERGING CLASSICAL PHARMACEUTICS WITH CUTTING EDGE INNOVATION AND TECHNOLOGY

MERGING CLASSICAL PHARMACEUTICS WITH CUTTING EDGE INNOVATION AND TECHNOLOGY

MERGING CLASSICAL PHARMACEUTICS WITH CUTTING EDGE INNOVATION AND TECHNOLOGY

MERGING CLASSICAL PHARMACEUTICS WITH CUTTING EDGE INNOVATION AND TECHNOLOGY

MERGING CLASSICAL PHARMACEUTICS WITH CUTTING EDGE INNOVATION AND TECHNOLOGY